Used primarily in neuroscience research as a selective inhibitor of the excitatory amino acid transporter 1 (EAAT1), UCPH-101 helps investigate glutamate transport mechanisms in the central nervous system. It is utilized to study the role of glutamate uptake in synaptic transmission, neuroprotection, and neurological disorders such as epilepsy, stroke, and neurodegenerative diseases. Due to its specificity, it serves as a valuable tool for modulating glutamate levels in experimental models, allowing researchers to dissect the function of EAAT1 in both normal and pathological conditions.